ALGN vs PATH · P/E 35, rev $4.00B vs P/E 19, rev $1.61B
Align Technology Inc (ALGN) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ALGN revenue for 2024-12-31 was $4.00B. Net income was $421.4M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ALGN and PATH stock pages for the full models.
Not investment advice.